ABSTRACT − Physicians treating patients with epilepsy have a host of thera-peutic options. Drug choice is dictated first by the seizure(s) and/or epilepsy syndrome. Age is also a factor. Special considerations apply to women, particu-larly during their childbearing years, and to patients who are learning-disabled. Drug selection is further influenced by such characteristics as spectrum of activity, rapid response, low potential for drug-drug interactions, and ease of use. In addition to clinical trial data, postmarketing assessments of the new antiepileptic drugs provide useful clinical information on efficacy and safety. Levetiracetam has specific characteristics that make it an optimal choice for many patient populations
With the advent of new antiepileptic drugs comes the potential for significant advances in the emerg...
AbstractLevetiracetam is highly effective as add-on treatment in refractory partial-onset seizures b...
With epilepsy being one of the most common neurological disorders, there is constant research hoping...
ABSTRACT − Physicians treating patients with epilepsy have a host of thera-peutic options. Drug choi...
Epilepsy is one of the commonest neurological conditions. For historical reasons, this condition is ...
Objective - This prospective, open-label study was conducted to evaluate the effectiveness, tolerabi...
AbstractThis prospective observational study explored the efficacy and tolerability of levetiracetam...
Epilepsy is a chronic, frequently encountered neurological disease, demanding long-term treatment wi...
AbstractBackgroundThe role of new antiepileptic drugs (AED) in the treatment of status epilepticus (...
Rationale: Levetiracetam (LEV) is a newantiepileptic drug (AED) indicated as adjunctive therapy in t...
Epilepsy is a common clinical problem in patients with brain tumours, strongly affecting patients’ q...
AbstractThis prospective open-label study used flexible dosing schedules of levetiracetam (LEV) in p...
Intractable epilepsy still remains the main issue despite new advances in medical and surgical treat...
Since 1993, 8 new antiepileptic drugs (AEDs) and 4new dosage forms of older medications have receive...
Rationale: The aim of this study is to evaluate efficacy and tolerability of levetiracetam (LEV), as...
With the advent of new antiepileptic drugs comes the potential for significant advances in the emerg...
AbstractLevetiracetam is highly effective as add-on treatment in refractory partial-onset seizures b...
With epilepsy being one of the most common neurological disorders, there is constant research hoping...
ABSTRACT − Physicians treating patients with epilepsy have a host of thera-peutic options. Drug choi...
Epilepsy is one of the commonest neurological conditions. For historical reasons, this condition is ...
Objective - This prospective, open-label study was conducted to evaluate the effectiveness, tolerabi...
AbstractThis prospective observational study explored the efficacy and tolerability of levetiracetam...
Epilepsy is a chronic, frequently encountered neurological disease, demanding long-term treatment wi...
AbstractBackgroundThe role of new antiepileptic drugs (AED) in the treatment of status epilepticus (...
Rationale: Levetiracetam (LEV) is a newantiepileptic drug (AED) indicated as adjunctive therapy in t...
Epilepsy is a common clinical problem in patients with brain tumours, strongly affecting patients’ q...
AbstractThis prospective open-label study used flexible dosing schedules of levetiracetam (LEV) in p...
Intractable epilepsy still remains the main issue despite new advances in medical and surgical treat...
Since 1993, 8 new antiepileptic drugs (AEDs) and 4new dosage forms of older medications have receive...
Rationale: The aim of this study is to evaluate efficacy and tolerability of levetiracetam (LEV), as...
With the advent of new antiepileptic drugs comes the potential for significant advances in the emerg...
AbstractLevetiracetam is highly effective as add-on treatment in refractory partial-onset seizures b...
With epilepsy being one of the most common neurological disorders, there is constant research hoping...